Rogliani P, Matera MG, Ora J, Cazzola M, Calzetta L. Int J Chron Obstruct Pulmon Dis. 2017;12:3469–3485.
Page 3481, right column, last paragraph, line 3, the text “(fromoterol and indacaterol)” should read “(formoterol and indacaterol)”.
. 2018 Oct 31;13:3597. doi: 10.2147/COPD.S192178
The impact of dual bronchodilation on cardiovascular serious adverse events and mortality in COPD: a quantitative synthesis [Corrigendum]
Collection date 2018.
© 2018 Rogliani et al. This work is published and licensed by Dove Medical Press Limited
The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
PMCID: PMC6219409 PMID: 30464442
This corrects the article "The impact of dual bronchodilation on cardiovascular serious adverse events and mortality in COPD: a quantitative synthesis" in volume 12 on page 3469.